CRI 31st Annual Awards Dinner Each year, we honor outstanding individuals whose contributions to cancer research—through scientific discovery or corporate and philanthropic leadership—have significantly advanced our mission to conquer cancer through immunotherapy. On Tuesday, November 14, 2017, the Cancer Research Institute will bestow its highest honors on Bill Anderson, Bruce Ratner, Rafi Ahmed, PhD, Thomas F. Gajewski, MD, PhD, and Shannon Turley, PhD, who, like CRI, are dedicated to fueling the development of immunotherapies for all forms of cancer. Honoring Bill Anderson Chief Executive Officer, Genentech Receiving the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research Bruce Ratner Philanthropist and NYC Real Estate Developer Receiving the Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research Rafi Ahmed, PhD Director, Emory Vaccine Center and Professor of Microbiology and Immunology, Emory University Receiving the William B. Coley Award for Distinguished Research in Tumor Immunology Thomas F. Gajewski, MD, PhD Professor, Department of Biology, The University of Chicago Receiving the William B. Coley Award for Distinguished Research in Tumor Immunology Shannon Turley, PhD Principal Scientist, Cancer Immunology, Genentech Receiving the Frederick W. Alt Award for New Discoveries in Immunology Read more: Post navigation Biomarkers in Cancer Immunotherapy: How Much Do They Matter? Read Story 2018 Frontiers in Cancer Immunotherapy Read Story